NCT00492050 2026-03-11Bortezomib and Rituximab for Patients With Waldenstrom's MacroglobulinemiaM.D. Anderson Cancer CenterPhase 2 Active not recruiting46 enrolled 10 charts
NCT03620903 2025-12-05Efficacy of First Line B-RI for Treatment Naive Waldenström's MacroglobulinemiaUniversity of UlmPhase 2 Active not recruiting53 enrolled